7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution

It is entirely fair to state that weight loss treatments have massive transformational power. US FDA approval of weight loss medicines could help shrink millions of waistlines. All while boosting weight loss stocks, which we’ve already seen happen with Eli Lilly’s Zepbound, for example. The best part — there are even more weight loss stocks that could see a similar boost, including:Novo Nordisk (NVO)Source: joreks / Shutterstock.comNovo Nordisk (NYSE:NVO) produces Ozempic and Wegovy. Although the two drugs ...